# reload+after+2024-01-21 04:46:27.937139
address1§400 Water Street
address2§Suite 200
city§Rochester
state§MI
zip§48307
country§United States
phone§248 651 6568
website§https://www.optimizerx.com
industry§Health Information Services
sector§Healthcare
longBusinessSummary§OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow. The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution, which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems. In addition, it provides Patient Engagement, a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow, a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was founded in 2006 and is headquartered in Rochester, Michigan.
fullTimeEmployees§109
companyOfficers§[{'maxAge': 1, 'name': 'Mr. William J. Febbo', 'age': 54, 'title': 'CEO & Director', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 694400, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Stephen L. Silvestro', 'age': 45, 'title': 'President', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 458600, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Edward  Stelmakh C.M.A., M.B.A.', 'age': 57, 'title': 'CFO & COO', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 547050, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': "Mr. Andrew Jacob D'Silva", 'title': 'Senior Vice President of Corporate Finance', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Todd  Inman', 'age': 67, 'title': 'Chief Technology Officer', 'yearBorn': 1956, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Marion K Odence-Ford', 'age': 58, 'title': 'General Counsel & Chief Compliance Officer', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 428117, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Maira  Alejandra', 'title': 'Media Relations Manager', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sheryl  Kearney', 'title': 'Human Resources Manager', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Terence J. Hamilton', 'age': 58, 'title': 'Senior Vice President of Pharma', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 441632, 'exercisedValue': 0, 'unexercisedValue': 1068672}, {'maxAge': 1, 'name': 'Dr. Doug  Besch', 'age': 41, 'title': 'Chief Product Officer', 'yearBorn': 1982, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§9
boardRisk§5
compensationRisk§10
shareHolderRightsRisk§4
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.991
priceToSalesTrailing12Months§3.8295183
currency§USD
dateShortInterest§1702598400
forwardEps§0.38
pegRatio§2.05
exchange§NCM
quoteType§EQUITY
shortName§OptimizeRx Corporation
longName§OptimizeRx Corporation
firstTradeDateEpochUtc§1196260200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§fa5dfbee-c9fe-3930-8f1d-3d3307c72117
gmtOffSetMilliseconds§-18000000
targetHighPrice§20.0
targetLowPrice§13.0
targetMeanPrice§15.2
targetMedianPrice§14.0
recommendationMean§1.8
recommendationKey§buy
numberOfAnalystOpinions§5
quickRatio§10.956
grossMargins§0.59727
ebitdaMargins§-0.22139
trailingPegRatio§None
